The estrogen-dependent upregulation of these genes and the suppression of their expression by ERβ overexpression in the cell line were further validated by semi-quantitative PCR (Figure 2) in cells treated for 30 hours with E2 to replicate prolonged estrogen exposure of breast tumor cells in vivo. The gene discussed is ESR2; the disease is breast neoplasm.